Nancy M. McClellan, MPH, CIH, CHMM, is an award winning, Industrial Hygiene and Safety expert with over 25 years of broad international experience practicing, teaching and authoring to anticipate, recognize, evaluate, control and prevent workplace health and safety hazards in high hazard industries.
Ms. McClellan is domestically and internationally recognized for leadership service to the IH profession for the American Industrial Hygiene Association (AIHA), the American Board of Industrial Hygiene (ABIH), the Occupational Hygiene Training Association (OHTA) and the Joint Industrial Hygiene Ethics Education (JIHEEC) Boards of Directors and Committees. She currently serves on the AIHA Executive Board of Directors.
Planned and carried out evaluation and exposure assessment of global drug supply management resulting in >55% reduction in respiratory personal protective equipment in clinical packaging operations. Completed initiative resulted in potential total reduction of >70% respiratory protection equipment as new engineering controls were implemented and evaluated for controlling pharmaceutical dust.
Developed and executed strategy for assessing potential IDLH chemical release during missile destruction testing. Outcome enabled missile scientists to safely enter the test site and collect time-critical data.
Provided expert witnessing to nationally profiled, occupational health cases in multiple states.
Executed reduction of >70% respiratory personal protective equipment for potent compound isolators as result of statistical analysis of occupational hygiene data, saving time and materials and eliminating need to transport active pharmaceutical ingredients between facilities.
Identified and addressed the mysterious source of staphylococcus biohazard in canning industry to address epidemic and prevent further widespread infections among workers.
Developed and instituted IH programs through effective change management process, impacting 85 countries, increasing engineering control implementation and reducing need for quantitative-evaluation consulting services by over 20%.
Planned and executed highly potent (HPAPI) compound containment risk assessment and management strategy, achieving 50% improvement in potent compound containment across global manufacturing in 5 years, fully engaging engineering, operations and EHS communities in reaching goal.
Designed sustainable industrial hygiene risk assessment strategy and tools, addressing prioritization of industrial hygiene goals and resources, resulting in 32% increase in manufacturing site exposure assessments and global program engagement.
Reviewed, planned, and prepared EHS response to Statement of Work for TPMs, required for first trial as third-party manufacturer in clinical supply operations, leading team in completing multiple rounds of production of highly potent compound for other major pharmaceutical companies in collaboration with global pharmaceutical operations in high-containment facility.
Served as volunteer leader for past 9 years for globally-endorsed Occupational Hygiene Training Association (OHTA) for development and proliferation of free, public-domain training modules, collaborating in creating module materials taught in over 55 countries and officially training over 8000 students regarding OH technical skills to universally impact and grow occupational hygiene profession.
Directly addressed IH competency in global corporations by implementing training curriculum, impacting over 100 health and safety staff by providing endorsed training materials and tools for manufacturing-site-level industrial hygiene programs.
Mold, pollen, dust, smog, smoke, carbon dioxide, volatile organic compounds (VOCs), and other viruses and bacteria released through materials like furniture upholstery and carpeting, gaseous chemicals, particulates, and occupants, can all impact and jeopardize human health. Investing in healthier indoor air now will lead to a better environment in your building as we emerge from this pandemic with occupants that are more productive and focused.